直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 118985
著者
板東, 浩 Tokushima University|Medical Research|Japan Low Carbohydrate Diet Promotion Association|Hayashi Hospital KAKEN研究者をさがす
Hayashi, Kenji Hayashi Hospital
Sumitomo, Kyoko Hayashi Hospital
Miki, Kazuya Hayashi Hospital
Kamoto, Asami Hayashi Hospital
キーワード
Oral Semaglutide
Rybelsus
Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate
Geriatric Depression Scale
Mirtazapine
Noradrenergic and Specific Serotonergic Antidepressant
Multiple Meta-Analyses of New Generation Antidepressants Study
資料タイプ
学術雑誌論文
抄録
Background: Oral semaglutide (Rybelsus) has been in focus for type 2 diabetes (T2D).
Case Presentation: The patient is a 73-year-old male with T2D treated with metformin, Ipragliflozin, and rosuvastatin. He was diagnosed with depression by the Geriatric depression scale (GDS) with a stable condition by mirtazapine. His diabetic control was exacerbated to HbA1c 8.8% and weight 63.5kg in Feb 2022.
Results: He started to take Rybelsus, and then clinical improvement was found as HbA1c 6.9% and weight 57.5kg for 4 months.
Discussion: Remarkable effect of HbA1c and weight may be from longer fasting time after post-med, and regular lifestyle from the stable psychosomatic situation.
掲載誌名
Asploro Journal of Biomedical and Clinical Case Reports
ISSN
25820370
出版者
Asploro
5
2
開始ページ
73
終了ページ
78
発行日
2022-07-23
権利情報
This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系